Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis
Status:
Unknown status
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the therapeutic efficacy of allogenic bone marrow
stem cells (BMSCs) transplantation in patients with liver cirrhosis. The evaluation of the
efficacy includes the level of serum alanine aminotransferase (ALT), aspartate
aminotransferase(AST), total bilirubin (TB),prothrombin time (PT), albumin (ALB),
prealbumin(PA), precollagenⅢ(PCⅢ), collagenⅣ(Ⅳ-C), laminin(LN), hyaluronidase(HN), liver
histological improvement before and 1 week to 1 year after transplantation. Child-Pugh scores
and clinical symptoms were also observed simultaneously.